Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties for 2024-2025.
Our ERs are staffed 24/7 with doctors, nurses and staff who know kids best – all trained to deliver right-sized care for your child in a safe environment.
Arkansas Children's provides right-sized care for your child. U.S. News & World Report has ranked Arkansas Children's in seven specialties for 2024-2025.
When you give to Arkansas Children's, you help deliver on our promise of a better today and a healthier tomorrow for the children of Arkansas and beyond
When you give to Arkansas Children’s, you help deliver on our promise of a better today and a healthier tomorrow for the children of Arkansas and beyond.
Discover opportunities to participate in groundbreaking research studies and clinical trials designed to support families managing Allergy, Asthma, and Eosinophilic esophagitis (EoE) conditions.
A phase I open-label trial to assess the tolerability and safety of an up-dosing regimen with a once-daily peanut SLIT-tablet in adults, adolescents, and children with peanut allergy.
A Phase 1b/2, randomized, double-blind, placebo-controlled, multicenter study of STMC-103H in neonates and infants at risk for developing
allergic disease.
If you are allergic to peanuts, you know it’s difficult to avoid them. We're running a trial to see if an investigational oral pill can give people with peanut allergies an extra layer of protection.
The goal of this research study is to examine how effective a personalized, interactive asthma smartphone app in reducing asthma disease among adolescents age 12-20 years, who are at greater risk for future asthma attacks.
Español 
Cookie Settings 
Accessibility